Meeting
2020 Genitourinary Cancers Symposium
Outcomes of men with ductal prostate cancer undergoing definitive therapy for localized disease.
Authors
Weranja Kalana Bodhisiri Ranasinghe
University of Texas MD Anderson Cancer Center, Houston, TX
Weranja Kalana Bodhisiri Ranasinghe , Daniel D. Shapiro , Chad A. Reichard , Mohamed A Elsheshtawi , Yaw Nyame , Debasish Sundi , Jeffrey J. Tosoian , Lamont Wilkins , Ridwan Alam , Tharakeswara Bathala , Chad Tang , Ana Aparicio , Shi-Ming Tu , Nora Navone , Louis L. Pisters , Andrew J. Stephenson , Eric A. Klein , Mohamad E. Allaf , Brian Francis Chapin , John W. Davis
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 350)
Abstract #
350
Poster Bd #
N12
Abstract Disclosures
Similar Posters
Poster
2013 Genitourinary Cancers Symposium
Assocation of Gleason 9-10 prostate cancer with worse outcomes compared to Gleason 8 disease.
First Author: Che-Kai Tsao
Poster
2021 Genitourinary Cancers Symposium
Management of localized prostate cancer during the Covid-19 pandemic at a multidisciplinary cancer center in New York City, New York.
First Author: Andrew Wood
Poster
2020 Genitourinary Cancers Symposium
Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.
First Author: Howard M. Sandler
Poster
2020 Genitourinary Cancers Symposium
Late toxicity and quality of life from GETUG-AFU 22 study.
First Author: Igor Latorzeff